|
1
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dunn MW and Kazer MW: Prostate cancer
overview. Semin Oncol Nurs. 27:241–250. 2011. View Article : Google Scholar
|
|
3
|
McCloskey DE, Casero RA Jr, Woster PM and
Davidson NE: Induction of programmed cell death in human breast
cancer cells by an unsymmetrically alkylated polyamine analogue.
Cancer Res. 55:3233–3236. 1995.PubMed/NCBI
|
|
4
|
Huang Y, Hager ER, Phillips DL, et al: A
novel polyamine analog inhibits growth and induces apoptosis in
human breast cancer cells. Clin Cancer Res. 9:2769–2777.
2003.PubMed/NCBI
|
|
5
|
Zhang L and Webster TJ:
Poly-lactic-glycolic-acid surface nanotopographies selectively
decrease breast adenocarcinoma cell functions. Nanotechnology.
23:1551012012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mertens-Talcott SU, Noratto GD, Li X,
Angel-Morales G, Bertoldi MC and Safe S: Betulinic acid decreases
ER-negative breast cancer cell growth in vitro and in vivo: role of
Sp transcription factors and microRNA-27a:ZBTB10. Mol Carcinog. Mar
7–2012.(Epub ahead of print). View
Article : Google Scholar
|
|
7
|
Zhang X, Zhang S, Liu Y, et al: Effects of
the combination of RAD001 and docetaxel on breast cancer stem
cells. Eur J Cancer. 48:1581–1592. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thapa D and Ghosh R: Antioxidants for
prostate cancer chemoprevention: challenges and opportunities.
Biochem Pharmacol. 83:1319–1330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar R, Verma V, Jain A, Jain RK,
Maikhuri JP and Gupta G: Synergistic chemoprotective mechanisms of
dietary phytoestrogens in a select combination against prostate
cancer. J Nutr Biochem. 22:723–731. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huang CH, Guh JH, Chen GS, Lu PH and Chern
JW: Anticancer activity of a cyclooxygenase inhibitor, CX9051, in
human prostate cancer cells: the roles of NF-κB and crosstalk
between the extrinsic and intrinsic apoptotic pathways. Naunyn
Schmiedebergs Arch Pharmacol. 382:159–169. 2010.PubMed/NCBI
|
|
11
|
Lim S, Janzer A, Becker A, et al:
Lysine-specific demethylase 1 (LSD1) is highly expressed in
ER-negative breast cancers and a biomarker predicting aggressive
biology. Carcinogenesis. 31:512–520. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schmidt DM and McCafferty DG:
trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of
the histone demethylase LSD1. Biochemistry. 46:4408–4416. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cortez V, Mann M, Tekmal S, et al:
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy
for breast cancer. Breast Cancer Res. 14:R1082012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Flamand V, Zhao H and Peehl DM: Targeting
monoamine oxidase A in advanced prostate cancer. J Cancer Res Clin
Oncol. 136:1761–1771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schulte JH, Lim S, Schramm A, et al:
Lysine-specific demethylase 1 is strongly expressed in poorly
differentiated neuroblastoma: implications for therapy. Cancer Res.
69:2065–2071. 2009. View Article : Google Scholar
|
|
16
|
Lee HT, Jung KH, Kim SK, Choi MR and Chai
YG: Effects of pargyline on cellular proliferation in human breast
cancer cells. Mol Cell Toxicol. 8:393–399. 2012. View Article : Google Scholar
|
|
17
|
Lee HT, Kim SK, Choi MR, Park JH, Jung KH
and Chai YG: Effects of the activated mitogen-activated protein
kinase pathway via the c-ros receptor tyrosine kinase on the
T47D breast cancer cell line following alcohol exposure. Oncol Rep.
29:868–874. 2013.PubMed/NCBI
|
|
18
|
Baik SY, Jung KH, Choi MR, et al:
Fluoxetine-induced up-regulation of 14-3-3zeta and tryptophan
hydroxylase levels in RBL-2H3 cells. Neurosci Lett. 374:53–57.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi MR, Oh DH, Kim SH, et al: Fluoxetine
up-regulates Bcl-xL expression in rat C6 glioma cells. Psychiatry
Investig. 8:161–168. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
21
|
Pollock JA, Larrea MD, Jasper JS,
McDonnell DP and McCafferty DG: Lysine-specific histone demethylase
1 inhibitors control breast cancer proliferation in ERα-dependent
and -independent manners. ACS Chem Biol. 7:1221–1231.
2012.PubMed/NCBI
|
|
22
|
Benelkebir H, Hodgkinson C, Duriez PJ, et
al: Enantioselective synthesis of tranylcypromine analogues as
lysine demethylase (LSD1) inhibitors. Bioorg Med Chem.
19:3709–3716. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim SJ, Min HY, Lee EJ, et al: Growth
inhibition and cell cycle arrest in the G0/G1 by schizandrin, a
dibenzocyclooctadiene lignan isolated from Schisandra
chinensis, on T47D human breast cancer cells. Phytother Res.
24:193–197. 2010.PubMed/NCBI
|
|
24
|
Chuang JY, Chang WC and Hung JJ: Hydrogen
peroxide induces Sp1 methylation and thereby suppresses cyclin B1
via recruitment of Suv39H1 and HDAC1 in cancer cells. Free Radic
Biol Med. 51:2309–2318. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gatta R and Mantovani R: NF-Y substitutes
H2A-H2B on active cell-cycle promoters: recruitment of CoREST-KDM1
and fine-tuning of H3 methylations. Nucleic Acids Res.
36:6592–6607. 2008. View Article : Google Scholar
|
|
26
|
Martinou JC and Youle RJ: Mitochondria in
apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev
Cell. 21:92–101. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rosser CJ, Gaar M and Porvasnik S:
Molecular fingerprinting of radiation resistant tumors: can we
apprehend and rehabilitate the suspects? BMC Cancer. 9:2252009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lucken-Ardjomande S and Martinou JC:
Regulation of Bcl-2 proteins and of the permeability of the outer
mitochondrial membrane. CR Biol. 328:616–631. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Oda E, Ohki R, Murasawa H, et al: Noxa, a
BH3-only member of the Bcl-2 family and candidate mediator of
p53-induced apoptosis. Science. 288:1053–1058. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Smith AJ, Dai H, Correia C, et al:
Noxa/Bcl-2 protein interactions contribute to bortezomib resistance
in human lymphoid cells. J Biol Chem. 286:17682–17692. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ploner C, Kofler R and Villunger A: Noxa:
at the tip of the balance between life and death. Oncogene.
27(Suppl 1): S84–S92. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shibue T, Takeda K, Oda E, et al: Integral
role of Noxa in p53-mediated apoptotic response. Genes Dev.
17:2233–2238. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Adams JM and Cory S: The Bcl-2 protein
family: arbiters of cell survival. Science. 281:1322–1326. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Elmore S: Apoptosis: a review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Malorni W, Giammarioli AM, Matarrese P, et
al: Protection against apoptosis by monoamine oxidase A inhibitors.
FEBS Lett. 426:155–159. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Singh MM, Manton CA, Bhat KP, et al:
Inhibition of LSD1 sensitizes glioblastoma cells to histone
deacetylase inhibitors. Neuro Oncol. 13:894–903. 2011. View Article : Google Scholar : PubMed/NCBI
|
